<DOC>
	<DOCNO>NCT01826279</DOCNO>
	<brief_summary>The purpose study investigate potential metabolic effect resveratrol morbidly obese woman undergo gastric bypass surgery . The investigator hypothesize resveratrol : - Decrease hepatic very-low-density-lipoprotein-triglyceride ( VLDL-TG ) secretion - Decrease hepatic adipose tissue VLDL-TG uptake - Increase insulin sensitivity The investigator look change : - Lipid turnover ( VLDL-TG kinetics , palmitate kinetics , calorimetry ) - VLDL-TG uptake different tissue ( subcutaneous femoral adipose tissue , subcutaneous abdominal adipose tissue , visceral adipose tissue liver tissue ) - Insulin sensitivity ( glucose kinetics hyperinsulinaemic euglycaemic clamp ) - Regulation liver fat handle - Lipoprotein lipase activity fat cell size ( abdominal femoral adipose tissue )</brief_summary>
	<brief_title>Short-term Investigation Resveratrol Fat Metabolism Morbidly Obese Women Undergoing Gastric Bypass Surgery</brief_title>
	<detailed_description />
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Female 2560 year Obesity ( BMI &gt; 35 kg/m2 ) Have least one element metabolic syndrome either hypertension and/or hypercholesterolemia ( high triglyceride , low HDLcholesterol ) Undergoing gastric bypass surgery Written inform consent Any relevant disease ( e.g . diabetes , thyroid parathyroid disease , heart , kidney liver disease ) May arthrosis depression Any present previous malignancy History smoking Alcohol dependency ( 14 unit alcohol per week ) Participation study radioactive isotope within last six month Hemoglobin normal range regard sex ( 7.3 mmol/l woman )</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Gastric bypass surgery</keyword>
	<keyword>Resveratrol</keyword>
	<keyword>Insulin sensitivity</keyword>
	<keyword>Lipid turnover</keyword>
	<keyword>VLDL-triglyceride uptake</keyword>
	<keyword>Liver</keyword>
</DOC>